Hepion (HEPA) Back in the Spotlight, Gains 230% in May.
Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...
Draganfly (DFLYF) Holds ‘Pole Position’ in Race for Drone Supremacy After Chinese Barred from...
STREETWISE REPORTS - March 3, 2020
The company establishes a toehold with U.S....
ChatGPT, the Biggest Thing Since the Internet.
Gary and Tanner talk about racking up 2.5 million views on Instagram Reels, how ChatGPT is influencing content creation.
AI and Machine Learning Start-Up Nowigence (NWGO) Announces Deal With EquiPPP Technologies (NSE: EQIPPP).
Nowigence CEO Anoop Bhatia was voted most innovative AI NLP Company CEO 2020.With over two decades in various GE companies across different...
ChatGPT: Write a Song About Wall Street Using Style of Michael Jackson, Frank Sinatra..
...Snoop Dog, Elton John, Whitney Houston and Bruce Springsteen.
Write a song about the stock market using Michael...
Adding Hepion Pharma (HEPA) $1.73 to Watch List.
Adding Hepion Pharma ($1.73) to Watch List. Oh My. What Did We Find Here?
Oh my…and Oh boy....
OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.
Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share.
Without disrupting legacy sales - CEO Shai...
OMNIQ (OMQS) to Begin Trading on NASDAQ
100% Here, 100% There, Pretty Soon it all Adds up. Our Sixth Client to Graduate to NASDAQ.
Yes, some...
Corporate Presentation: Internet of Things Innovator, Direct Communication (DCSX).
CORPORATE PRESENTATION | 8-2022
#DCSX
GBT (GTCH) Is Researching To Develop An AI Empowered, Wireless Patient Health Monitoring System
The researched technology, is aiming to create a Radio-Based patient health monitoring system for homes or facilities
SAN...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
